Medical Xpress news
Medical Xpress / High-puff e-cigarettes may become more toxic with use, researchers warn
A University of California, Riverside-led study has found that heavily used high-puff electronic cigarettes may contain higher levels of harmful chemicals than fresh e-cigarettes, raising concerns about potential health risks ...
Medical Xpress / Social media bans for teenagers lack evidence and pose risks, scientists say
Bans on teenagers' social media use are gathering pace worldwide. Their proponents claim that social media bans will improve young people's mental health, but what evidence supports these claims? In their new Frontiers in ...
Medical Xpress / How lifestyle can protect childhood cancer survivors
Healthy lifestyles can reduce the risk of cardiovascular disease and other complications in childhood cancer survivors. These are the findings of two new international studies.
Medical Xpress / Scientists uncover how Alzheimer's may quietly begin years before memory loss appears
A new Columbia study has found clues of Alzheimer's beginnings, revealing how tau filaments—protein clumps that are closely linked to memory decline in Alzheimer's disease—get their start. The finding raises the prospect ...
Medical Xpress / Simulation-guided search uncovers two promising tuberculosis drug candidates targeting CYP
A research team led by Associate Professor Noriyuki Kurita from the Department of Computer Science and Engineering at Toyohashi University of Technology and by Associate Professor Pornpan Pungpo from Ubon Ratchathani University ...
Medical Xpress / Why metformin matters beyond diabetes: New target could reshape aging and cancer research
Scientists at Université de Montréal have figured out how metformin—a common drug that's used to treat type-2 diabetes and that may cut the risk of developing cancer and even help humans and other mammals live longer—actually ...
Medical Xpress / Targeted drug outperforms chemotherapy for patients with hard-to-treat lung cancer
The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR exon 20 insertion mutations ...
Medical Xpress / Blood biomarkers reveal subtle midlife cognitive decline tied to Alzheimer's risk
For the first time, researchers found blood biomarkers for Alzheimer's disease that correlated with minor cognitive differences in midlife adults who did not have dementia. The study, led by UC San Francisco, also found that ...
Medical Xpress / New brain scan detects Alzheimer's tau earlier than current standard
A new brain imaging test can detect a key hallmark of Alzheimer's disease before symptoms appear and earlier than the method currently used in clinical practice in the United States and Europe, report University of Pittsburgh ...
Medical Xpress / AI-powered atlas reveals new insights into tertiary lymphoid structures as prognostic and response biomarkers in cancer
In a study published in Science, researchers from The University of Texas MD Anderson Cancer Center have developed a spatial atlas of specialized immune structures, called tertiary lymphoid structures (TLSs), across multiple ...
Medical Xpress / Ocrelizumab cuts disability progression in primary progressive MS trial
A major international Phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab—a medication already prescribed to some patients with MS—significantly slows disability progression in people ...
Medical Xpress / Unprecedented view inside live stem cells reveals aging process and loss of regenerative capacity
Scientists have developed a powerful new technique that allows them to observe how individual cells manufacture proteins during aging, offering an unprecedented glimpse into the hidden molecular activity of stem cells in ...
